BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17374732)

  • 21. Expression of SOCS-1, suppressor of cytokine signalling-1, in human melanoma.
    Li Z; Metze D; Nashan D; Müller-Tidow C; Serve HL; Poremba C; Luger TA; Böhm M
    J Invest Dermatol; 2004 Oct; 123(4):737-45. PubMed ID: 15373779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Signal transducer and activator of transcription 3 (STAT3) and Suppressor of Cytokine Signaling (SOCS3) balance controls cytotoxicity and IL-10 expression in decidual-like natural killer cell line NK-92.
    Braunschweig A; Poehlmann TG; Busch S; Schleussner E; Markert UR
    Am J Reprod Immunol; 2011 Oct; 66(4):329-35. PubMed ID: 21385272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling.
    Fischer P; Lehmann U; Sobota RM; Schmitz J; Niemand C; Linnemann S; Haan S; Behrmann I; Yoshimura A; Johnston JA; Müller-Newen G; Heinrich PC; Schaper F
    Biochem J; 2004 Mar; 378(Pt 2):449-60. PubMed ID: 14611646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of suppressor of cytokine signalling 3 (SOCS3) in human bladder epithelial cells infected with uropathogenic Escherichia coli.
    Demirel I; Säve S; Kruse R; Persson K
    APMIS; 2013 Feb; 121(2):158-67. PubMed ID: 23030674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Negative regulation of onconstatin M signaling by suppressor of cytokine signaling (SOCS-3).
    Magrangeas F; Boisteau O; Denis S; Jacques Y; Minvielle S
    Eur Cytokine Netw; 2001; 12(2):309-15. PubMed ID: 11399520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of SOCS protein expression influences the interferon responsiveness of human melanoma cells.
    Lesinski GB; Zimmerer JM; Kreiner M; Trefry J; Bill MA; Young GS; Becknell B; Carson WE
    BMC Cancer; 2010 Apr; 10():142. PubMed ID: 20398276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective role of STAT3 in NMDA and glutamate-induced neuronal death: negative regulatory effect of SOCS3.
    Park KW; Nozell SE; Benveniste EN
    PLoS One; 2012; 7(11):e50874. PubMed ID: 23226414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the SOCS3 promoter response to prostaglandin E2 in T47D cells.
    Barclay JL; Anderson ST; Waters MJ; Curlewis JD
    Mol Endocrinol; 2007 Oct; 21(10):2516-28. PubMed ID: 17636039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of oncostatin M receptor beta in metastatic melanoma cells.
    Lacreusette A; Nguyen JM; Pandolfino MC; Khammari A; Dreno B; Jacques Y; Godard A; Blanchard F
    Oncogene; 2007 Feb; 26(6):881-92. PubMed ID: 16909117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of SOCS3 increases susceptibility of renal cell carcinoma to interferon-α.
    Tomita S; Ishibashi K; Hashimoto K; Sugino T; Yanagida T; Kushida N; Shishido K; Aikawa K; Sato Y; Suzutani T; Yamaguchi O
    Cancer Sci; 2011 Jan; 102(1):57-63. PubMed ID: 21054677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of SOCS3 phosphorylation upon interleukin-6 stimulation. Contributions of Src- and receptor-tyrosine kinases.
    Sommer U; Schmid C; Sobota RM; Lehmann U; Stevenson NJ; Johnston JA; Schaper F; Heinrich PC; Haan S
    J Biol Chem; 2005 Sep; 280(36):31478-88. PubMed ID: 16000307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
    Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R
    J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon.
    Rigby RJ; Simmons JG; Greenhalgh CJ; Alexander WS; Lund PK
    Oncogene; 2007 Jul; 26(33):4833-41. PubMed ID: 17297444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IFN-alpha-induced signal transduction, gene expression, and antitumor activity of immune effector cells are negatively regulated by suppressor of cytokine signaling proteins.
    Zimmerer JM; Lesinski GB; Kondadasula SV; Karpa VI; Lehman A; Raychaudhury A; Becknell B; Carson WE
    J Immunol; 2007 Apr; 178(8):4832-45. PubMed ID: 17404264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic tumor necrosis factor-alpha treatment causes insulin resistance via insulin receptor substrate-1 serine phosphorylation and suppressor of cytokine signaling-3 induction in 3T3-L1 adipocytes.
    Ishizuka K; Usui I; Kanatani Y; Bukhari A; He J; Fujisaka S; Yamazaki Y; Suzuki H; Hiratani K; Ishiki M; Iwata M; Urakaze M; Haruta T; Kobayashi M
    Endocrinology; 2007 Jun; 148(6):2994-3003. PubMed ID: 17379643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transfer of suppressor of cytokine signaling 3 by an oncolytic adenovirus induces potential antitumor activities in hepatocellular carcinoma.
    Cui Q; Jiang W; Wang Y; Lv C; Luo J; Zhang W; Lin F; Yin Y; Cai R; Wei P; Qian C
    Hepatology; 2008 Jan; 47(1):105-12. PubMed ID: 17935223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. STAT3 activation in response to IL-6 is prolonged by the binding of IL-6 receptor to EGF receptor.
    Wang Y; van Boxel-Dezaire AH; Cheon H; Yang J; Stark GR
    Proc Natl Acad Sci U S A; 2013 Oct; 110(42):16975-80. PubMed ID: 24082147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of microtubule-associated protein 1S in SOCS3 regulation of IL-6 signaling.
    Zou T; Ouyang L; Chen L; Dong W; Qiao H; Liu Y; Qi Y
    FEBS Lett; 2008 Dec; 582(29):4015-22. PubMed ID: 19027008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased resistance to oncostatin M-induced growth inhibition of human melanoma cell lines derived from advanced-stage lesions.
    Lu C; Rak JW; Kobayashi H; Kerbel RS
    Cancer Res; 1993 Jun; 53(12):2708-11. PubMed ID: 8504408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppressors of cytokine signaling (SOCS) 1 and SOCS3 interact with and modulate fibroblast growth factor receptor signaling.
    Ben-Zvi T; Yayon A; Gertler A; Monsonego-Ornan E
    J Cell Sci; 2006 Jan; 119(Pt 2):380-7. PubMed ID: 16410555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.